Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Erku, Daniel Asfaw ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; COMORBIDITY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EORTC QLQ-C30 QUESTIONNAIRE; ETHIOPIA; FEMALE; HEALTH CARE PERSONNEL; HERBAL MEDICINE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 84982813106     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/2809875     Document Type: Article

References (38)

1. Y. W. Woldeamanuel, B. Girma, and A. M. Teklu, "Cancer in Ethiopia, " The Lancet Oncology, vol. 14, no. 4, pp. 289-290, 2013.
2. J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers, and D. Parkin, GLOBO-CAN 2015, Cancer Incidence and MortalityWorldwide: IARC Cancer-Base No. 10, International Agency for Research on Cancer, Lyon, France, 2015, http://globocan. iarc. fr.
3. National Center for Complementary and Alternative Medicine (NCCAM), "What is complementary and alternative medicine?" 2010, https://nccih. nih. gov/.
4. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., "Use of complementary and alternative medicine in cancer patients: a European survey, " Annals of Oncology, vol. 16, no. 4, pp. 655-663, 2005.
5. M. Horneber, G. Bueschel, G. Dennert, D. Less, E. Ritter, and M. Zwahlen, "How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis, " Integrative CancerTherapies, vol. 11, no. 3, pp. 187-203, 2012.
6. C. Bautista, T. Moehler, and R. Joubert, "CAM use in Asia-Pacific, " Applied Clinical Trials, vol. 6, pp. 12-13, 2011.
7. C. L. LimandM. Kandiah, "Dietary supplementation and alternative medicine practices among cancer survivors at Hospital Kuala Lumpur, " Malaysian Journal of Nutrition, vol. 12, no. 2, pp. S102-S103, 2006.
8. M. Frenkel, E. Ben-Arye, and L. Cohen, "Communication in cancer care: discussing complementary and alternative medicine, " Integrative Cancer Therapies, vol. 9, no. 2, pp. 177-185, 2010.
9. J. Addington-Hall and L. Kalra, "Measuring quality of life: who should measure quality of life?" BritishMedical Journal, vol. 322, no. 7299, pp. 1417-1420, 2001.
10. P. L. Chui, K. L. Abdullah, L. P. Wong, and N. A. Taib, "Qualityof life in CAM and Non-CAM users among breast cancer patients during chemotherapy in Malaysia, " PLoS ONE, vol. 10, no. 10, Article ID e0139952, 2015.
11. M. Farooqui, M. A. Hassali, A. Knight et al., "The use of Energy Medicines (EM), Manipulative Body BasedTherapies(MBBT), therapies from Whole Medical Systems (WMS) and Health RelatedQuality of Life (HRQoL) of cancer patients, " Alternative & IntegrativeMedicine, vol. 2, no. 5, article 121, 2013.
12. G. Can and A. Aydiner, "Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey, " European Journal of Oncology Nursing, vol. 15, no. 1, pp. 3-11, 2011.
13. A. Saini, A. Berruti, S. Capogna et al., "Prevalence of complementary/ alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features, " Quality of Life Research, vol. 20, no. 5, pp. 683-690, 2011.
14. G. Wyatt, A. Sikorskii, C. E. Wills, and H. Su, "Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer, " Nursing Research, vol. 59, no. 1, pp. 58-66, 2010.
15. L. G. Balneaves, J. L. Bottorff, T. G. Hislop, and C. Herbert, "Levels of commitment: exploring complementary therapy use by women with breast cancer, " Journal of Alternative & Complementary Medicine, vol. 12, no. 5, pp. 459-466, 2006.
16. Legal Status of Traditional Medicine and Complementary/ Alternative Medicine: A worldwide review, 2016, http://apps. who. int/medicinedocs/en/d/Jh2943e/4. 16. html#Jh2943e. 4. 16.
17. N. K. Aaronson, S. Ahinedzai, B. Bergman et al., "TheEuropean Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, " Journal of the National Cancer Institute, vol. 85, no. 5, pp. 365-376, 1993.
18. A. Montazeri, I. Harirchi, M. Vahdani et al., "The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version, " Supportive Care in Cancer, vol. 7, no. 6, pp. 400-406, 1999.
19. Y. H. Yun, Y. S. Park, E. S. Lee et al., "Validation of the Korean version of the EORTC QLQ-C30, " Quality of Life Research, vol. 13, no. 4, pp. 863-868, 2004.
20. H. Zhao and K. Kanda, "Translation and validation of the standard Chinese version of the EORTC QLQ-C30, " Quality of Life Research, vol. 9, no. 2, pp. 129-137, 2000.
21. N. Tadele, "Evaluation of quality of life of adult cancer patients attending Tikur Anbessa specialized referral hospital, Addis Ababa Ethiopia, " Ethiopian Journal of Health Sciences, vol. 25, no. 1, article 53, 2015.
22. P. M. Fayers, N. K. Aaronson, K. Bjordal, M. Groenvold, D. Curran, and A. Bottomley, The EORTC QLQ-C30 Scoring Manual, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 3rd edition, 2001.
23. A. Molassiotis, J. A. Scott, N. Kearney et al., "Complementary and alternative medicine use in breast cancer patients in Europe, " Supportive Care in Cancer, vol. 14, no. 3, pp. 260-267, 2006.
24. H. Greenlee, M. L. Kwan, I. J. Ergas et al., "Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study, " Breast Cancer Research and Treatment, vol. 117, no. 3, pp. 653-665, 2009.
25. A. C. C. Alfano, C. E. Paiva, F. C. Rugno, R. H. da Silva, and B. S. R. Paiva, "Biologically based therapies are commonly selfprescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms, " Supportive Care in Cancer, vol. 22, no. 5, pp. 1303-1311, 2014.
26. S. M. Ock, J. Y. Choi, Y. S. Cha et al., "The use of complementary and alternative medicine in a general population in South Korea: results from a national survey in 2006, " Journal of Korean Medical Science, vol. 24, no. 1, pp. 1-6, 2009.
27. M. Saghatchian, C. Bihan, C. Chenailler, C. Mazouni, S. Dauchy, and S. Delaloge, "Exploring frontiers: use of complementary and alternative medicine among patients with early-stage breast cancer, " The Breast, vol. 23, no. 3, pp. 279-285, 2014.
28. P. Puataweepong, N. Sutheechet, and P. Ratanamongkol, "A survey of complementary and alternative medicine use in cancer patients treated with radiotherapy inThailand, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 670408, 6 pages, 2012.
29. O. Tarhan, A. Alacacioglu, I. Somali et al., "Complementaryalternative medicine among cancer patients in the western region of Turkey, " Journal of B. U. ON., vol. 14, no. 2, pp. 265-269, 2009.
30. C. L. Carpenter, P. A. Ganz, and L. Bernstein, "Complementary and alternative therapies among very long-term breast cancer survivors, " Breast Cancer Research and Treatment, vol. 116, no. 2, pp. 387-396, 2009.
31. O. Er, S. Mistik, M. Ozkan, A. Ozturk, and M. Altinbas, "Factors related to complementary/alternative medicine use among cancer patients in central Anatolia, " Tumori, vol. 94, no. 6, pp. 833-837, 2008.
32. H. J. Chung, M. R. Kim, J. S. Bae et al., "Complementary and alternative medicine in patients with breast cancer, " Journal of Breast Cancer, vol. 9, no. 4, pp. 361-366, 2006.
33. E. Tautz, F. Momm, A. Hasenburg, and C. Guethlin, "Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study, " European Journal of Cancer, vol. 48, no. 17, pp. 3133-3139, 2012.
34. E. Kang, E. J. Yang, S.-M. Kim et al., "Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study, " Supportive Care in Cancer, vol. 20, no. 3, pp. 461-473, 2012.
35. F. Naja, R. A. Fadel, M. Alameddine et al., "Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study, " BMC Complementary and Alternative Medicine, vol. 15, article 444, 2015.
36. T. Ashikaga, K. Bosompra, P. O'Brien, and L. Nelson, "Use of complimentary and alternative medicine by breast cancer patients: Prevalence, patterns and communication with physicians, " Supportive Care in Cancer, vol. 10, no. 7, pp. 542-548, 2002.
37. A. Wanchai, J. M. Armer, and B. R. Stewart, "Complementary and alternative medicine use among women with breast cancer: a systematic review, " Clinical Journal of Oncology Nursing, vol. 14, no. 4, pp. E45-E55, 2010.
38. K. Tasaki, G. Maskarinec, D. M. Shumay, Y. Tatsumura, and H. Kakai, "Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives, " Psycho-Oncology, vol. 11, no. 3, pp. 212-220, 2002.